The BalancedInvestor Club

Biotechnology Industry Analysis

717 companies analyzed • Returns from -682.4% to +648.5%

Company List (719 Results)

View:
Sort:

Industry Performance

(717/717 companies)
2025-06-18 → 2026-06-16
Weighted Avg
+28.1%
Best
+648.5%
Worst
-682.4%
Returns Distribution
Top 5
1. SPRB+648.5%2. PTNT+520.7%3. CUBT+514.2%4. MRSN+440.3%5. VOR+418.9%
Bottom 5
1. CERO-682.4%2. LEXXW-521.1%3. ADTX-487.0%4. LIMN-472.3%5. CARM-444.4%

SPRB

+648.5%

Spruce Biosciences Inc

PTNT

+520.7%

Internet Patents Corp

CUBT

+514.2%

Curative Biotechnology Inc

MRSN

+440.3%

Mersana Therapeutics Inc

VOR

+418.9%

Vor Biopharma Inc

RLYB

+388.7%

Rallybio Corp

CUE

+359.6%

Cue Biopharma

STRO

+356.9%

Sutro Biopharma

SPRC

+329.5%

Scisparc Ltd

ATHA

+327.8%

Athira Pharma Inc

LONA

+323.6%

Athira Pharma Inc

PTHS

+315.1%

Pelthos Therapeutics Inc.

RVMDW

+314.4%

Revolution Medicines, Inc. Warrant

PSTV

+311.6%

Plus Therapeutics Inc

PMN

+301.2%

ProMIS Neurosciences Inc.

ASBP

+296.9%

Aspire BioPharma, Inc.

IMUX

+291.1%

Immunic Inc

ABVX

+278.0%

Abivax SA American Depositary Shares

GBIO

+269.7%

Generation Bio Co

NCNA

+268.4%

NuCana PLC

1–20 of 719
Page 1 of 36
Methodology

The Weighted Average return (+28.1%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

669 companies with market cap data included: SPRB, CUBT, MRSN, VOR, RLYB, CUE, STRO, SPRC, ATHA, LONA and 659 more...

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer